Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage
European Journal of Pharmaceutics and Biopharmaceutics · 2026
DOI: 10.1016/j.ejpb.2026.115221 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Yawen Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: BAICSM, State Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 10…. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Viral Vaccines, Vaccines, Virus-Like Particle, Levivirus. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Porcine epidemic diarrhea virus (PEDV) can infect pigs of all ages, causing porcine epidemic diarrhea and resulting in significant losses to the global pig farming industry. The virus causes epidemic diarrhea and represents a significant threat to the global swine industry. To enhance vaccine safety and protective efficacy, a PEDV nanoparticle vaccine (PEDV-MS2 VLP) based on MS2 bacteriophages was developed. The MS2 phage coat (MS2 VLP) self-assembles into nanoparticles within Escherichia coli. It is conjugated to the PEDV RBD antigen via the SpyTag-SpyCatcher system, forming a structure mimicking the natural virus. Subcutaneous immunization of BALB/c mice with PEDV-MS2 VLP at days 0 and 14 resulted in a 100-fold increase in neutralizing titers and robust antigen-specific IgG responses. Additionally, PEDV-MS2 VLP induced high levels of cytokines (TNF-α, IFN-γ). The vaccine showed no significant toxicity to the liver, kidneys, or heart in mice. In summary, PEDV-MS2 VLPs demonstrate excellent safety and are a novel candidate vaccine for porcine epidemic diarrhea virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- BAICSM, State Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
- BAICSM, State Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: shanxu@buct.edu.cn.
- BAICSM, State Key Laboratory of Green Biomanufacturing, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: tongyigang@mail.buct.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Du, S., Xu, S., & Tong, Y. (2026). Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115221
Vancouver
Liu Y, Du S, Xu S, Tong Y. Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115221
BibTeX
@article{Liu2026,
author = {Liu, Yawen and Du, Siying and Xu, Shan and Tong, Yigang},
title = {Development and evaluation of a virus-like particle PEDV vaccine based on MS2 bacteriophage},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
doi = {10.1016/j.ejpb.2026.115221}
}
EUVIMED